Clinical Investigation & Informatics, DRTC - Johns Hopkins University/University of Maryland

DRTC Baltimore Clinical Investigation Core :

The DRTC Clinical Investigation Core (CIC) will serve as the central resource to facilitate the conduct of clinical investigation in diabetes and predisposing associated conditions. It will offer a wide range of state-of-the-art diabetes- and obesity-, and CVD-related clinical research tests and assessments, as well as diet, exercise, and pharmacological interventions to probe mechanisms of disease. CIC leaders will provide consultation and training to DRTC investigators and guidance/mentoring for young investigators in the design and implementation of clinical investigative approaches in T2DM.

Clinical Investigation Core objectives:

• Offer standardized state-of-the-art assessments of glucose and fat metabolism, insulin sensitivity, p-cell function, body composition/fat distribution, energy homeostasis, cardiovascular, and functional capacity
• Perform DRTC-investigator initiated intervention studies, including diet/weight loss (WL), exercise, and pharmacological
• Provide consultation and guidance to investigators in the application of clinical physiology, body composition, and metabolic measurements
• Engage basic science DRTC investigators in multidisciplinary patient-oriented research
• Engage investigators outside the field of diabetes in interdisciplinary research
• provide an educational resource for all DRTC investigators, and training opportunities for junior faculty, fellows and students
• Develop a DRTC Research Subject Registry with the Control and Prevention Core
• Maintain a tissue bank consisting of DNA, RNA, leukocytes, body fluids, and fat and muscle tissue from well-characterized subjects

Andrew Goldberg, MD - Director
Alan Shuldiner, MD - Director

People :

Alan Shuldiner, M.D. : Center Co-Director and Director, Clinical Investigation Core, . Phone: 410-706-1623

Andrew P. Goldberg, M.D. : Director, Clinical Investigation Core, . Phone: 410-605-7183